Michael Young, formerly vice president of commercial development at Genzyme Transgenics, has been appointed to the newly created position of vice president of business development at Reykjavik, Iceland-based DeCode Genetics.
Young will oversee the development of new partnerships for DeCode’s research programs and product offerings in gene discovery, pharmacogenomics, drug and diagnostic development, and database and bioinformatics products and services. BioWisdom of Cambridge, UK, has appointed Julie Barnes as director of life sciences.
Barnes, who was previously head of the department of neuropharmacology research at GlaxoSmithKline (formerly GlaxoWellcome) will lead BioWisdom’s team of life science analysts who position information about public and proprietary drug discovery and development resources within the company’s Discovery Portfolio platform.
She will join the company on June 25.